ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer

Li, Yue; Li, Chong; Jiang, Ya; Han, Xue; Liu, Sisi; Xu, Xiuxiu; Tang, Wanxiangfu; Ou, Qiuxiang; Bao, Hua; Wu, Xue; Shao, Yang; Xing, Minyan; Zhang, Yixiang*; Wang, Yuezhen*哈尔滨医科大学; 苏州大学; 中国科学院研究生院; 1
Journal of Oncology2022-4-11DOI: 10.1155/2022/1763778
1被引5阅读
引用收藏
分享

摘要

Programmed cell death 1 ligand 1 (PD-L1) has been approved as predictive biomarker for non-small-cell lung cancer (NSCLC) patients treated with PD-(L)1 blockade therapy. The clinical/genomic features associated with PD-L1 are not well studied. Genomic profiling of tumor biopsies from 883 Chinese NSCLC patients was performed by targeted next-generation sequencing. Immunohistochemical analysis was conducted to evaluate PD-L1 expression levels using antibodies Dako 22C3 and 28-8, respectively. Our study showed distinct correlation between PD-L1 expression and clinical/genomic characteristics when using different PD-L1 antibodies and in different histological subtypes including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), respectively. PD-L1 high expression (22C3) was associated with male and lymph node metastasis only in ADC patients. Furthermore, mutations of TP53 and KRAS, KIF5B-RET fusion, copy number gains of PD-L1 and PD-L2, and arm-level amplifications of chr.12p were significantly associated with PD-L1 positive status in ADC patients. For SCC patients, the gain of EGFR and MDM2 and loss of PTPRD were negatively associated with PD-L1 expression. We also compared our results with other studies and found conflicting results presumably because of the multiplicity of antibody clones and platforms, the difference of cutoffs for assigning PD-L1 expression levels, and the variation in study populations. Our study can help to understand the utility and validity of PD-L1 as biomarker of response to immune checkpoint inhibitors.

学科与关键词

关键词
MUTATIONSBLOCKADELIGANDOVEREXPRESSIONPEMBROLIZUMABHETEROGENEITYASSOCIATIONACTIVATIONASSAYSTP53
相关
加载中…
  • Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Li, Kang; Liu, Jun; Wu, Lin; Xiao, Yajie; Li, Jia; Du, Haijian; Zhao, Zhikun; Sun, Chao; Zhao, Yongtian; Yang, Jie; Wu, Dongfang; Zhao, Zhuxiang*; Chen, Bolin*Cancer Cell International, 2022, 22(1): 138.被引 7
  • In-depth genomic characterization of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.
    Kang, Li; Liu, Jun; Li, Jia; Wu, Lin; Xiao, Yajie; Du, Haijian; Zhao, Zhikun; Li, Xiaoting; Wu, Dongfang; Zhao, Zhuxiang; Chen, BolinVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2021-06-04 To 2021-06-08.
  • Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations
    Li, Kai; Cao, Li; Li, Cheukfai; Wu, Jundong; Chen, Bo; Zhang, Guochun; Li, Xueri; Wen, Lingzhu; Jia, Minghan; Wei, Guangnan; Lin, Jiali; Li, Yingzi; Zhang, Yuchen; Mok, Hsiaopei; Ren, Chongyang; Wang, Yulei; Qi, Xiaofang; Guo, Lijie; Che, Yue; Liao, Ning*Cancer Medicine, 2023, 12(5): 5195-5208.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-04-11
卷期
第 2022 卷
页码
1763778
DOI
10.1155/2022/1763778
期刊等级
4区
成果收录
SCIE
资助标注
Zhejiang Natural Science Foundation [20160171]

作者

  • L

    Li, Yue (第一作者)

    harbin med univ

  • L

    Li, Chong

    soochow univ

查看全部 14 位作者收起作者
  • J

    Jiang, Ya

  • H

    Han, Xue

  • L

    Liu, Sisi

  • X

    Xu, Xiuxiu

  • T

    Tang, Wanxiangfu

  • O

    Ou, Qiuxiang

  • B

    Bao, Hua

  • W

    Wu, Xue

  • S

    Shao, Yang

  • X

    Xing, Minyan

  • Z

    Zhang, Yixiang (通讯)

    1 · dalian med univ

  • W

    Wang, Yuezhen (通讯)

    chinese acad sci, inst canc · univ chinese acad sci · zhejiang canc hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417